Mendelian randomisation analyses find pulmonary factors mediate the effect of height on coronary artery disease

Autor: Shafqat Ahmad, Christina M Astley, Ruth J. F. Loos, Evangelos Evangelou, M. Fabiola Del Greco, Barbara McKnight, Helen R. Warren, Sonja I. Berndt, Carolina Medina-Gomez, Eirini Marouli, Jana V. van Vliet-Ostaptchouk, Joel N. Hirschhorn, Panos Deloukas, Zhihong Zhu, Mark J. Caulfield, Zoltán Kutalik, Jian Yang
Přispěvatelé: Center for Liver, Digestive and Metabolic Diseases (CLDM), Epidemiology, Internal Medicine
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
SELECTION
Vital capacity
Heart disease
endocrine system diseases
Vital Capacity
Medicine (miscellaneous)
Type 2 diabetes
Coronary Artery Disease
Body Mass Index
Coronary artery disease
Cohort Studies
0302 clinical medicine
Risk Factors
Forced Expiratory Volume
Medicine
030212 general & internal medicine
Lung
lcsh:QH301-705.5
2. Zero hunger
RISK
0303 health sciences
ASSOCIATION
Middle Aged
MULTIPLE GENETIC-VARIANTS
BIAS
Cardiology
Female
General Agricultural and Biological Sciences
Medical Genetics
Adult
medicine.medical_specialty
Genotype
HEART-DISEASE
Polymorphism
Single Nucleotide

General Biochemistry
Genetics and Molecular Biology

Article
03 medical and health sciences
FEV1/FVC ratio
Diabetes mellitus
Internal medicine
INSTRUMENTAL VARIABLES
Humans
030304 developmental biology
Aged
Medicinsk genetik
business.industry
MORTALITY
nutritional and metabolic diseases
Mendelian Randomization Analysis
medicine.disease
Body Height
United Kingdom
Blood pressure
Diabetes Mellitus
Type 2

lcsh:Biology (General)
ATHEROSCLEROSIS
PLEIOTROPY
business
Body mass index
Zdroj: Communications Biology, Vol 2, Iss 1, Pp 1-9 (2019)
Communications biology, 2:119. Nature Publishing Group
Communications Biology
Communications biology, vol. 2, pp. 119
Communications Biology, 2:119. Springer Nature
ISSN: 2399-3642
DOI: 10.1038/s42003-019-0361-2
Popis: There is evidence that lower height is associated with a higher risk of coronary artery disease (CAD) and increased risk of type 2 diabetes (T2D). It is not clear though whether these associations are causal, direct or mediated by other factors. Here we show that one standard deviation higher genetically determined height (~6.5 cm) is causally associated with a 16% decrease in CAD risk (OR = 0.84, 95% CI 0.80–0.87). This causal association remains after performing sensitivity analyses relaxing pleiotropy assumptions. The causal effect of height on CAD risk is reduced by 1–3% after adjustment for potential mediators (lipids, blood pressure, glycaemic traits, body mass index, socio-economic status). In contrast, our data suggest that lung function (measured by forced expiratory volume [FEV1] and forced vital capacity [FVC]) is a mediator of the effect of height on CAD. We observe no direct causal effect of height on the risk of T2D.
Eirini Marouli et al. use Mendelian randomisation analyses to investigate the causal relationship between adult height, coronary artery disease (CAD) and type 2 diabetes (T2D) in the UK Biobank. They find that height has a causal effect on CAD, which is mediated by lung function, while there is no direct effect on the risk of T2D.
Databáze: OpenAIRE